TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies

Clinical trial NCT06484816 · RECRUITING

Trial details

NCT number: NCT06484816
Sponsor: Shenzhen TargetRx Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Advanced Solid Tumor Hematologic Malignancy

Start date: 2024-07-08
Primary completion: 2027-02-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.